SCHEMBL8319638

SCHEMBL8319638

[CH2]N1CCN(c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.65
SMN1; SMN2 Q16637 7/20 0.65
LMNA P02545 4/20 0.65
ALOX12 P18054 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
ADRB1 P08588 1/20 0.61
HTT P42858 5/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
MAPK1 P28482 1/20 0.54
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 1/20 0.53
GAA P10253 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
RAB9A P51151 1/20 0.51
USP2 O75604 1/20 0.50
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8318822 0.85 MAPT (0.62) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL5618735 0.82 MAPT (0.67) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL9830834 0.81 ADRB1 (0.68) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL423400 0.80 MAPT (0.65) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL27918171 0.79 MAPT (0.69) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL7715055 0.79 ADRB1 (0.66) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL8320134 0.79 NOTUM (0.52) MAPTSMN1; SMN2LMNAMEN1KMT2A
SCHEMBL631834 0.78 MAPT (0.68) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL27953332 0.78 MAPT (0.68) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL5543934 0.78 MAPT (0.68) MAPTSMN1; SMN2LMNAALOX12L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5945421-A TREATING PSYCHOSIS AND SCHIZOPHRENIA WARNER-LAMBERT COMPANY (US) 1999-08-31 US disclosed